1 483 172 CLINICAL EFFICACY OF VAMANA KARMA WITH IKSHWAAKU BEEJA YOGA FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF ARTAVA KSHAYA W. S. R TO POLYCYSTIC OVARIAN SYNDROME. BACKGROUND: DUE TO SEDENTARY LIFESTYLE AND STRESS, THE INCIDENCE OF METABOLIC DISORDERS ARE INCREASING DAY BY DAY. AMONG THESE POLYCYSTIC OVARIAN SYNDROME (PCOS) IS AN INTRICATE DISORDER AFFECTING 4%-8% WOMEN IN THEIR REPRODUCTIVE AGE AND RELATED TO OVARIAN DYSFUNCTION CHARACTERIZED BY OBESITY, OLIGOMENORRHEA, ANOVULATION AND HYPERANDROGENISM. IN MODERN SYSTEM OF MEDICINE, THE AVAILABLE ALLOPATHIC REGIMEN HAS ITS OWN LIMITATIONS, SO IT IS NEED OF TIME TO FIND A SAFE AND EFFECTIVE ALTERNATIVE THERAPY FOR SUCH TYPE OF CONDITION. THE MOST COMMON SYMPTOM IN 85%-90% OF PCOS PATIENTS IS OLIGOMENORRHEA WHICH CAN BE CORRELATED TO ARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) IN AYURVEDA. HENCE, IN THE PRESENT CLINICAL STUDY, VAMANA KARMA (THERAPEUTIC VOMITING) WITH IKSHWAAKU SEED FORMULATION FOLLOWED BY SHATAPUSHPADI GHANAVATI WAS PLANNED. AIMS: TO EVALUATE THE EFFICACY OF VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF AARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) W. S. R TO PCOS. MATERIALS AND METHODS: A TOTAL OF 15 PATIENTS OF PCOS WERE CLINICALLY DIAGNOSED AND TREATED BY VAMANA KARMA (THERAPEUTIC VOMITING) PROCEDURE WITH IKSHWAAKU SEED FORMULATION. AFTER COMPLETION OF VAMANA KARMA (THERAPEUTIC VOMITING) AND SAMSARJANA KRAMA, (POST THERAPY DIETARY REGIMEN FOR REVIVAL) SHATAPUSHPADI GHANAVATI 2 VATI (EACH 500 MG) TWICE IN A DAY WITH LUKEWARM WATER WAS GIVEN FOR 45 DAYS. AFTER COMPLETION OF 2-MONTH TRIAL, ASSESSMENT OF THERAPY WAS ESTIMATED BY SUBJECTIVE AND OBJECTIVE PARAMETERS. RESULTS: STATISTICALLY EXTREMELY SIGNIFICANT (P < 0.0001) RESULTS WERE FOUND IN MENSTRUAL IRREGULARITIES, OBESITY, AND BODY MASS INDEX. THE SIGNIFICANT RESULT IN REDUCTION OF NONDOMINANT FOLLICLES (P = 0.01 AND 0.03 FOR RIGHT AND LEFT OVARY, RESPECTIVELY), LOWERING THE FASTING BLOOD SUGAR LEVEL (P = 0.02) AND HIRSUTISM (P = 0.03) WAS FOUND. CONCLUSION: VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IS VERY EFFECTIVE IN THE MANAGEMENT OF OBESE PCOS PATIENTS AND INCREASING CHANCES OF CONCEPTION. 2017 2 1128 54 EFFICACY OF VAMANA KARMA WITH IKSHVAKU KSHEERA YOGA IN THE MANAGEMENT OF TAMAKA SHVASA (BRONCHIAL ASTHMA). INTRODUCTION: BRONCHIAL ASTHMA IS A HIGHLY PREVALENT DISEASE, AND IN MOST OF THE ETIOPATHOGENESIS AND SYMPTOMATOLOGY, IT CAN BE CORRELATED WITH TAMAKA SHVASA. IKSHVAKU (LAGENARIA VULGARIS [MANILA] STANDLEY.) IS AN ANNUAL HERBACEOUS CLIMBING PLANT WITH A LONG HISTORY OF MEDICINAL USES FOR THE TREATMENT OF VARIOUS AILMENTS INCLUDING JAUNDICE, DIABETES, ULCER, PILES, COLITIS, ASTHMA, INSANITY, HYPERTENSION, CONGESTIVE CARDIAC FAILURE AND SKIN DISORDERS. ITS FRUIT PULP IS USED BOTH AS AN EMETIC AND AS A PURGATIVE. AIMS: TO STUDY THE EFFICACY OF VAMANA KARMA WITH IKSHVAKU (LAGENARIA VULGARIS [MANILA] STANDLEY) KSHEERA YOGA. MATERIALS AND METHODS: A TOTAL OF 15 PATIENTS FULFILLING THE DIAGNOSTIC CRITERIA FOR BRONCHIAL ASTHMA WERE SELECTED FROM OUTPATIENT AND INPATIENT DEPARTMENT OF PANCHAKARMA DEPARTMENT. THE SIGN AND SYMPTOMS, MAINLY BREATHLESSNESS, COUGH AND RHONCHI WERE GIVEN SCORES DEPENDING ON THEIR SEVERITY. THE PATIENTS WERE ALSO ASSESSED FOR LUNG FUNCTION TEST TO DETERMINE PULMONARY IMPAIRMENT. FOR VAMANA, THEY WERE GIVEN DEEPANA AND PACHANA WITH TRIKATU CHURNA FOR 3 DAYS AND THEN THEY WERE SUBJECTED TO SNEHAPANA WITH LUKEWARM COW'S GHEE. AFTER THE COMPLETION OF SNEHAPANA, THE PATIENT WERE GIVEN ABHYANGA, VASHPA SWEDANA AND DIET WITH PREDOMINANCE OF KAPHA (KAPHA BAHULA AHARA- DIET MIXED WITH MILK OR CURD), WHICH WAS THEN FOLLOWED BY VAMANA WITH IKSHVAKU KSHEERA YOGA AND SAMSARJANA KRAMA. FOLLOW-UP WAS DONE AT AN INTERVAL OF 15 DAYS FOR THREE TIMES AND T SCORES WERE NOTED BEFORE AND AFTER THE TREATMENT. THE SCORES WERE ANALYZED USING WILCOXON SIGNED-RANK TEST FOR SUBJECTIVE PARAMETERS AND STUDENT'S PAIRED T-TEST FOR OBJECTIVE PARAMETERS. RESULTS: THE TRIAL DRUG HAS SHOWN STATISTICALLY HIGHLY SIGNIFICANT REDUCTION IN BREATHLESSNESS, COUGH, RHONCHI, AND SIGNIFICANT CHANGES IN LUNG FUNCTION TESTS. CONCLUSION: THE TEST DRUG PROVED ITS EMETIC EFFECT ON THE PATIENTS OF BRONCHIAL ASTHMA AND THUS RELIEVED THE SYMPTOMS OF THE DISEASE IMMEDIATELY. IT HAS REDUCED FREQUENCY OF EPISODES OF BREATHLESSNESS AND SEVERITY OF SYMPTOMS. 2017 3 684 35 EFFECT OF AN INTEGRATED APPROACH OF YOGA THERAPY ON QUALITY OF LIFE IN OSTEOARTHRITIS OF THE KNEE JOINT: A RANDOMIZED CONTROL STUDY. AIM: THIS STUDY WAS DESIGNED TO EVALUATE THE EFFICACY OF ADDITION OF INTEGRATED YOGA THERAPY TO THERAPEUTIC EXERCISES IN OSTEOARTHRITIS (OA) OF KNEE JOINTS. MATERIALS AND METHODS: THIS WAS A PROSPECTIVE RANDOMIZED ACTIVE CONTROL TRIAL. A TOTAL OF T PARTICIPANTS WITH OA OF KNEE JOINTS BETWEEN 35 AND 80 YEARS (YOGA, 59.56 +/- 9.54 AND CONTROL, 59.42 +/- 10.66) FROM THE OUTPATIENT DEPARTMENT OF DR. JOHN'S ORTHOPEDIC CENTER, BENGALURU, WERE RANDOMLY ASSIGNED TO RECEIVE YOGA OR PHYSIOTHERAPY EXERCISES AFTER TRANSCUTANEOUS ELECTRICAL STIMULATION AND ULTRASOUND TREATMENT OF THE AFFECTED KNEE JOINTS. BOTH GROUPS PRACTICED SUPERVISED INTERVENTION (40 MIN PER DAY) FOR 2 WEEKS (6 DAYS PER WEEK) WITH FOLLOWUP FOR 3 MONTHS. THE MODULE OF INTEGRATED YOGA CONSISTED OF SHITHILIKARANAVYAYAMA (LOOSENING AND STRENGTHENING), ASANAS, RELAXATION TECHNIQUES, PRANAYAMA, MEDITATION AND DIDACTIC LECTURES ON YAMA, NIYAMA, JNANA YOGA, BHAKTI YOGA, AND KARMA YOGA FOR A HEALTHY LIFESTYLE CHANGE. THE CONTROL GROUP ALSO HAD SUPERVISED PHYSIOTHERAPY EXERCISES. A TOTAL OF 118 (YOGA) AND 117 (CONTROL) WERE AVAILABLE FOR FINAL ANALYSIS. RESULTS: SIGNIFICANT DIFFERENCES WERE OBSERVED WITHIN (P < 0.001, WILCOXON'S) AND BETWEEN GROUPS (P < 0.001, MANN-WHITNEY U-TEST) ON ALL DOMAINS OF THE SHORT FORM-36 (P < 0.004), WITH BETTER RESULTS IN THE YOGA GROUP THAN IN THE CONTROL GROUP, BOTH AT 15(TH) DAY AND 90(TH) DAY. CONCLUSION: AN INTEGRATED APPROACH OF YOGA THERAPY IS BETTER THAN THERAPEUTIC EXERCISES AS AN ADJUNCT TO TRANSCUTANEOUS ELECTRICAL STIMULATION AND ULTRASOUND TREATMENT IN IMPROVING KNEE DISABILITY AND QUALITY OF LIFE IN PATIENTS WITH OA KNEES. 2011 4 1535 21 KARMA YOGA: A PATH TOWARDS WORK IN POSITIVE PSYCHOLOGY. KARMA YOGA IS THE PATH THAT LEADS TO SALVATION THROUGH ACTION. SALVATION IS THE ULTIMATE STATE OF CONSCIOUSNESS. WORK IS THE CENTRAL AND DEFINING CHARACTERISTIC OF LIFE. IT MAY HAVE INTRINSIC VALUE, INSTRUMENTAL VALUE, OR BOTH. INSTRUMENTAL VALUE INCLUDES INCENTIVE, DIGNITY AND POWER, ETC., WHICH IS THE RESULT EXPECTED FROM THE WORK. THE GITA TEACHES US TO DO WORK WITHOUT THINKING OF RESULT (WORK WITH INTRINSIC VALUE). ATTACHMENT WITH THE RESULT LEADS TO STRESS, COMPETITION AND AGGRESSION. STRESS FURTHER GIVES RISE TO HEART AILMENTS, DEPRESSION AND SUICIDE. POSITIVE PSYCHOLOGY STUDIES THE FACTORS AND CONDITIONS LEADING TO PLEASURABLE AND SATISFYING LIFE. UNDERSTANDING KARMA YOGA AND ITS PRACTICE HAS A SIMILAR ROLE THAT LEAD AN INDIVIDUAL TOWARDS WORK AND LEADING TO A SATISFIED LIFE. THIS MAY PLAY A UNIQUE ROLE TOWARDS PRACTICAL ASPECTS OF POSITIVE PSYCHOLOGY TO IMPROVE ONE'S LIFESTYLE AND AID IN THE TREATMENT OF STRESS DISORDERS. 2013 5 2283 46 THE USE OF INTEGRATIVE THERAPY BASED ON YOGA AND AYURVEDA IN THE TREATMENT OF A HIGH-RISK CASE OF COVID-19/SARS-COV-2 WITH MULTIPLE COMORBIDITIES: A CASE REPORT. BACKGROUND: WE REPORT A HIGH-RISK CASE OF A CORONAVIRUS DISEASE 19 (COVID-19)-POSITIVE PATIENT WITH COMORBIDITIES INCLUDING DIABETES MELLITUS (DM), HYPERTENSION (HTN), HYPOTHYROIDISM AND CHRONIC KIDNEY DISEASE (CKD), TREATED SUCCESSFULLY USING AN INTEGRATIVE THERAPY PLAN BASED ON AYURVEDA AND YOGA, ALONG WITH GOVERNMENT-MANDATED COMPULSORY MODERN WESTERN MEDICINE (MWM) TREATMENT. RECENTLY, SOME EVIDENCE HAS BEEN EMERGING ON THE USE OF AYURVEDA FOR TREATMENT OF COVID-19. THE CLASSICAL TEXTS OF AYURVEDIC MEDICINE SUCH AS CHARAKA SAMHITA AND SUSHRUTA SAMHITA CONTAIN DESCRIPTIONS OF PANDEMICS OF SIMILAR PROPORTIONS AND DESCRIBE THEM AS JANAPADODDHVANSA, MEANING THE DESTRUCTION OF COMMUNITIES, ALONG WITH THEIR CAUSES AND TREATMENT. CASE PRESENTATION: THE CASE REPORTED HEREIN IS A 55-YEAR-OLD MAN FROM DELHI, INDIA, WITH CONFIRMED (TESTED) COVID-19, WHO FIRST TOOK MWM FOR 7 DAYS BEFORE SEEKING INTEGRATIVE THERAPY. THE PATIENT HAS COMORBIDITIES INCLUDING DM, HTN, HYPOTHYROIDISM AND CKD AND HAD DEVELOPED SYMPTOMS INCLUDING FEVER (WHICH WAS RESOLVED BY THE TIME INTEGRATIVE THERAPY WAS STARTED), SORE THROAT, DRY COUGH, BODY ACHES, WEAKNESS, BAD TASTE AND SMELL, AND HEAVINESS IN THE ABDOMEN. BASED ON THE PATIENT'S SYMPTOMS AND COMORBIDITIES, A TREATMENT PLAN INCLUDING AYURVEDIC MEDICINES, YOGA PROTOCOL, DIETARY RECOMMENDATIONS AND LIFESTYLE MODIFICATIONS WAS PRESCRIBED BY A REGISTERED AYURVEDA DOCTOR AND A YOGA CONSULTANT. THE PATIENT STARTED EXPERIENCING IMPROVEMENT IN ALL THE SYMPTOMS WITHIN 2 DAYS AFTER STARTING THE TREATMENT; HE REPORTED APPROXIMATELY [FORMULA: SEE TEXT] RELIEF FROM THE SYMPTOMS AFTER 5 DAYS, AND ALMOST COMPLETE RELIEF WITHIN 9 DAYS. ALSO, THE BLOOD SUGAR LEVELS (BOTH FASTING BLOOD SUGAR [FBS] AND POSTPRANDIAL BLOOD SUGAR [PPBS]) EXHIBITED SIGNIFICANT IMPROVEMENT AFTER 5 DAYS, AND DECREASED TO WITHIN THE NORMAL RANGE WITHIN 12 DAYS. BESIDES RELIEF IN SYMPTOMS, THE PATIENT'S REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR) TEST DONE ON THE 19TH DAY RETURNED NEGATIVE RESULTS. CONCLUSIONS: INTEGRATIVE THERAPY WAS FOUND TO BE EFFECTIVE IN MITIGATING THE SYMPTOMS OF COVID-19 IN THIS PATIENT WITH MULTIPLE COMORBIDITIES. MOREOVER, A SIGNIFICANT IMPROVEMENT IN BLOOD SUGAR LEVELS (NOT UNDER CONTROL WITH MODERN MEDICINE) WAS ALSO ACHIEVED. INTEGRATIVE THERAPY BASED ON THE CLASSICAL TEXTS OF AYURVEDA AND YOGA MAY OFFER A PROMISING AND SCALABLE TREATMENT OPTION FOR COVID-19 PATIENTS. A CASE SERIES OR A SUITABLY DESIGNED RANDOMIZED CONTROLLED TRIAL IS NEEDED TO ASSESS ITS EFFICACY. 2021 6 704 39 EFFECT OF INTEGRATED APPROACH OF YOGA AND NATUROPATHY ON POLYCYSTIC OVARIAN SYNDROME: A CASE STUDY. OWING TO STRESS, SEDENTARY LIFESTYLE AND CHANGES IN DIET PATTERN, THERE IS AN INCREASE IN THE SURGE OF LIFESTYLE AND METABOLIC DISORDERS. POLYCYSTIC OVARIAN SYNDROME (PCOS) AFFECTS 8-13% OF REPRODUCTIVE-AGED WOMEN. PCOS IS CHARACTERISED BY MENSTRUAL IRREGULARITY, HYPERANDROGENISM AND POLYCYSTIC OVARIAN MORPHOLOGY (PCOM). THE EFFICACY OF YOGA AS A THERAPY TO TACKLE THE DIRECT AND INDIRECT CAUSE OF AILMENT IN THE MANAGEMENT OF PCOS IS TO BE DOCUMENTED. THIS IS THE CASE STUDY OF A FEMALE PATIENT AGE 25 YEARS, A DIAGNOSED CASE OF PCOS WAS REGISTERED AT THE AYURVEDA, YOGA, UNANI,SIDDHA,HOMEOPATHY (AYUSH), YOGA OPD, WITH COMPLAINTS OF IRREGULAR MENSTRUATION, TREATED SUCCESSFULLY BY YOGA AND NATUROPATHY (Y AND N), I.E., YOGA, DIET AND LIFESTYLE MODIFICATION. THIS IS EVIDENT FROM THE REDUCTION IN WEIGHT, REGULARISATION OF THE MENSTRUAL CYCLE ALONG WITH MORPHOLOGICAL CHANGES IN THE OVARY AFTER A FOLLOW-UP OF 6 MONTHS. 2022 7 867 49 EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY IN CORONARY ARTERY DISEASE PATIENTS: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: LUNG FUNCTIONS ARE FOUND TO BE IMPAIRED IN CORONARY ARTERY DISEASE (CAD), CONGESTIVE HEART FAILURE, LEFT VENTRICULAR DYSFUNCTION, AND AFTER CARDIAC SURGERY. DIFFUSION CAPACITY PROGRESSIVELY WORSENS AS THE SEVERITY OF CAD INCREASES DUE TO REDUCTION IN LUNG TISSUE PARTICIPATING IN GAS EXCHANGE. AIMS AND OBJECTIVES: PRANAYAMA BREATHING EXERCISES AND YOGIC POSTURES MAY PLAY AN IMPRESSIVE ROLE IN IMPROVING CARDIO-RESPIRATORY EFFICIENCY AND FACILITATING GAS DIFFUSION AT THE ALVEOLO-CAPILLARY MEMBRANE. THIS STUDY WAS DONE TO SEE THE EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS PARTICULARLY DIFFUSION CAPACITY IN CAD PATIENTS. MATERIALS AND METHODS: A TOTAL OF 80 STABLE CAD PATIENTS BELOW 65 YEARS OF AGE OF BOTH SEXES WERE SELECTED AND RANDOMIZED INTO TWO GROUPS OF 40 EACH. GROUP I CAD PATIENTS WERE GIVEN YOGA REGIMEN FOR 3 MONTHS WHICH CONSISTED OF YOGIC POSTURES, PRANAYAMA BREATHING EXERCISES, DIETARY MODIFICATION, AND HOLISTIC TEACHING ALONG WITH THEIR CONVENTIONAL MEDICINE WHILE GROUP II CAD PATIENTS WERE PUT ONLY ON CONVENTIONAL MEDICINE. LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY WERE RECORDED THRICE IN BOTH THE GROUPS: 0 DAY AS BASELINE, 22(ND) DAY AND ON 90(TH) DAY BY USING COMPUTERIZED MS MEDISOFT CARDIO-RESPIRATORY INSTRUMENT, HYP'AIR COMPACT MODEL OF CARDIO-RESPIRATORY TESTING MACHINE WAS MANUFACTURED BY P K MORGAN, INDIA. THE RECORDED PARAMETERS WERE STATISTICALLY ANALYZED BY REPEATED MEASURES ANOVA FOLLOWED BY TUKEY'S TEST IN BOTH THE GROUPS. CARDIOVASCULAR PARAMETERS WERE ALSO COMPARED BEFORE AND AFTER INTERVENTION IN BOTH THE GROUPS. RESULTS: STATISTICALLY SIGNIFICANT IMPROVEMENTS WERE SEEN IN SLOW VITAL CAPACITY, FORCED VITAL CAPACITY, PEAK EXPIRATORY FLOW RATE, MAXIMUM VOLUNTARY VENTILATION, AND DIFFUSION FACTOR/ TRANSFER FACTOR OF LUNG FOR CARBON MONOXIDE AFTER 3 MONTHS OF YOGA REGIMEN IN GROUP I. FORCED EXPIRATORY VOLUME IN 1(ST) SEC (FEV1), AND FEV1 % ALSO SHOWED A TREND TOWARD IMPROVEMENT ALTHOUGH NOT STATISTICALLY SIGNIFICANT. HR, SBP AND DBP ALSO SHOWED SIGNIFICANT IMPROVEMENT IN GROUP-I PATIENTS WHO FOLLOWED YOGA REGIMEN. CONCLUSIONS: YOGA REGIMEN WAS FOUND TO IMPROVE LUNG FUNCTIONS AND DIFFUSION CAPACITY IN CAD PATIENTS BESIDES IMPROVING CARDIOVASCULAR FUNCTIONS. THUS, IT CAN BE USED AS A COMPLIMENTARY OR ADJUNCT THERAPY ALONG WITH THE CONVENTIONAL MEDICINE FOR THEIR TREATMENT AND REHABILITATION. 2015 8 46 53 A CLINICO-ANALYTICAL STUDY ON SEED OF WRIGHTIA ANTIDYSENTERICA LINN. AS A THERAPEUTIC EMETIC AGENT (VAMAKA YOGA) IN THE MANAGEMENT OF PSORIASIS. OBJECTIVES: WRIGHTIA ANTIDYSENTERICA LINN. (WA) IS MALE VARIETY KUTAJA STATED TO BE POTENT THERAPEUTIC EMETIC AGENT IN SKIN DISORDERS. EXPULSION OF DOSHAS THROUGH ORAL ROUTE IS TERMED AS VAMANA KARMA (VK) (THERAPEUTIC EMESIS). HOWEVER, SO FAR, ITS UTILITY FOR VAMANA IS NOT EXPLORED IN DETAIL, THEREFORE THERE IS A NEED TO REVALIDATE THE UTILITY OF WA FOR VAMANA. HENCE, THE ABOVE STUDY WAS CONDUCTED TO ASCERTAIN THE EFFICACY AS A THERAPEUTIC EMETIC AGENT (VAMAKA YOGA) IN THE MANAGEMENT OF PSORIASIS ALONG WITH QUALITY CONTROL AND STANDARDIZATION OF THIS HERB. MATERIALS AND METHODS: THE DRUG WAS STANDARDIZED AS PER ANALYTICAL PROCEDURES IN PHARMACOPEIAS. THIRTY PATIENTS OF PSORIASIS FULFILLING INCLUSION CRITERIA WERE TAKEN FOR THE STUDY AND VAMANA WITH WA WAS CONDUCTED. CRITERIA WERE PREPARED TO ASSESS THE SIGNS AND SYMPTOMS OF PSORIASIS. VK WAS ASSESSED USING THE CLASSICAL LAKSHANAS (FEATURES) SUCH AS ANTHIKI SHUDHI (ENDING SYMPTOMS OF EMESIS), VAIGIKI SHUDHI (FEATURES OF VOMITING BOUTS), MANIKI SHUDHI (QUANTITATIVE AND QUALITATIVE PURIFICATION), COMPLICATIONS. RESULT: VK WITH WA SHOWED SIGNIFICANT RELIEF IN PARAMETERS OF PSORIASIS SUCH AS SCALING, ITCHING, CANDLE GREASE SIGN (P < 0.001), AND PSORIASIS AREA AND SEVERITY INDEX SCORE (P = 0.001). IN VK WITH WA, MEAN NUMBER OF VEGAS (VOMITING BOUTS) WAS 6.91. 66% PATIENTS SHOWING QUANTITATIVE PURIFICATION BETWEEN 301 AND 600 ML. 73.33% SHOWED ALL SYMPTOMS OF PURIFICATION. 73.33% PATIENTS SHOWED KAPHANTA VAMANA (MODERATE EXPULSION OF DESIRE HUMOR). IN THE LEVEL OF BIOPURIFICATION, 66.66% PATIENTS SHOWED MODERATED PURIFICATION. NO COMPLICATION WAS NOTED WITH MODERATE DRUG PALATABILITY. CONCLUSION: PHARMACOPEIAL ANALYTICAL STUDY SHOWED ITS STANDARDIZED VALUES FOR TESTING THE DRUG USED FOR THE STUDY. IT IS PROVED AS POTENT THERAPEUTIC EMETIC AGENT WITH NO COMPLICATION SHOWED ITS CLINICAL BENEFITS OVER SKIN DISORDER LIKE PSORIASIS. SUMMARY: SEEDS OF WRIGHTIA ANTIDYSENTERICA (WA) LINN. FREE FROM ANY FOREIGN MATTER WERE SELECTED FOR THE STUDY. LOSS ON DRYING REVEALED 6.535% MOISTURE CONTENT; TOTAL ASH INDICATING OF TOTAL INORGANIC CONTENT WAS FOUND TO BE 5.12%; ACID INSOLUBLE ASH IS THE ACID INSOLUBLE PART OF TOTAL ASH, MAINLY SILICA, WA SHOWED 0.393% ACID INSOLUBLE ASH; ETHANOL AND WATER SOLUBLE EXTRACTIVE IS INDICATIVE OF PERCENTAGE ACTIVE CONSTITUENTS WERE FOUND TO BE 25.66 AND 20.854%, RESPECTIVELY. HIGH-PERFORMANCE THIN LAYER CHROMATOGRAPHY FINGERPRINTING PROFILES OF WA UNDER 254 NM SHOWED THE PRESENCE OF 7 SPOTS (ALL IN GREEN) AT RF VALUES RANGING FROM 0.21 TO 0.88. UNDER 366 NM THERE WERE 4 PROMINENT SPOTS (ALL IN FLUORESCENT) AT RF 0.49 TO 0.82 AND, WHEN SCANNED UNDER WHITE LIGHT 620 NM FOLLOWING DERIVATIZATION WITH VANILLIN SULFURIC ACID 6 SPOTS (IN DIFFERENT COLORS) WERE EVIDENT AT RF 0.28 TO 0.58. AMONG THESE SPOT WITH RF OF 0.58 WAS COMMON WHEN VISUALIZED UNDER ALL THE THREE METHODS. RF VALUES BY DENSITOMETRIC SCAN OF WA SHOWED 12 PEAKS AT 254 NM AND 5 PEAKS AT 366 NM. HOWEVER, IN CLINICAL TRIAL, IT WAS FOUND TO BE A POTENT EMETIC AGENT WITHOUT ANY COMPLICATION. ABBREVIATIONS USED: WA: WRIGHTIA ANTIDYSENTERICA; LINN.; VK: VAMANA KARMA; BT: BEFORE TREATMENT; FP: FREIDMAN'S P VALUE; CHS: CHI-SQUARE VALUE; NR: NEGATIVE RANKS; PR: POSITIVE RANKS; N: SAMPLE NUMBER, AS: AUSTIPZ SIGN; CG: CANDLE GREASE TEST; SSL: SAMYAK SNIGDHA LAKSHANA. 2016 9 603 28 DEVELOPMENT AND VALIDATION OF INTEGRATED YOGA MODULE FOR OBESITY IN ADOLESCENTS. BACKGROUND: OBESITY IS A GROWING GLOBAL EPIDEMIC AND CAUSE OF NONCOMMUNICABLE DISEASES. YOGA IS ONE OF THE EFFECTIVE WAYS TO REDUCE STRESS WHICH IS ONE OF THE CAUSES OF OBESITY. NOWADAYS, CHILDREN IN ADOLESCENT AGE ARE MORE PRONE TO GET OBESE DUE TO LACK OF PHYSICAL ACTIVITY MAKING THEM MORE SEDENTARY. AIM: TO IDENTIFY THE DESIGN AND VALIDATION OF INTEGRATED APPROACH OF YOGA THERAPY MODULE (IAYTM) FOR OBESITY IN ADOLESCENTS. MATERIALS AND METHODS: FIRST PHASE - IAYTM FOR OBESITY WAS DESIGNED BASED ON THE LITERATURE REVIEW OF CLASSICAL TEXTS AND RECENTLY PUBLISHED RESEARCH ARTICLES. SECOND PHASE - DESIGNED IAYTM WAS VALIDATED BY 16 SUBJECT MATTER (YOGA) EXPERTS. CONTENT-VALIDITY RATIO (CVR) WAS ANALYZED USING LAWSHE'S FORMULA. RESULTS: YOGA PRACTICES WERE DESIGNED FOR INTEGRATED YOGA MODULE FOR OBESITY IN ADOLESCENTS. YOGA PRACTICES WITH CVR >/=0.5 AND WHICH WERE VALIDATED BY 16 YOGA EXPERTS AND APPROVED IN FACULTY GROUP DISCUSSION WERE INCLUDED IN FINAL INTEGRATED YOGA THERAPY MODULE. CONCLUSION: THE YOGA PRACTICES WERE DESIGNED AND VALIDATED FOR IAYTM FOR OBESITY IN ADOLESCENTS. 2018 10 373 28 AYURVEDA AND YOGA IN CARDIOVASCULAR DISEASES. AYURVEDA IS DERIVED FROM 2 SANSKRIT WORDS, NAMELY, "AYUS" AND "VEDA," MEANING LIFE AND KNOWLEDGE, RESPECTIVELY. IT LITERALLY MEANS SCIENCE OF LIFE. AYURVEDA, OF WHICH YOGA IS AN INTEGRAL PART, IS WIDELY PRACTICED IN INDIA AND IS GAINING ACCEPTANCE IN MANY COUNTRIES AROUND THE WORLD. IT IS A COMPREHENSIVE AND A HOLISTIC SYSTEM, THE FOCUS OF WHICH IS ON THE BODY, MIND, AND CONSCIOUSNESS. THE AYURVEDIC TREATMENT CONSISTS OF THE USE HERBAL PREPARATIONS, DIET, YOGA, MEDITATION, AND OTHER PRACTICES. BASED ON THE REVIEW OF AVAILABLE STUDIES, THE EVIDENCE IS NOT CONVINCING THAT ANY AYURVEDIC HERBAL TREATMENT IS EFFECTIVE IN THE TREATMENT OF HEART DISEASE OR HYPERTENSION. HOWEVER, THE USE OF CERTAIN SPICES AND HERBS SUCH AS GARLIC AND TURMERIC IN AN OVERALL HEALTHY DIET IS APPROPRIATE. MANY HERBS USED BY AYURVEDIC PRACTITIONERS SHOW PROMISE AND COULD BE APPROPRIATE FOR LARGER RANDOMIZED TRIALS. YOGA, AN INTEGRAL PART OF AYURVEDA, HAS BEEN SHOWN TO BE USEFUL TO PATIENTS WITH HEART DISEASE AND HYPERTENSION. YOGA REDUCES ANXIETY, PROMOTES WELL-BEING, AND IMPROVES QUALITY OF LIFE. ITS SAFETY PROFILE IS EXCELLENT. ITS USE AS A COMPLEMENTARY THERAPEUTIC REGIMEN UNDER MEDICAL SUPERVISION IS APPROPRIATE AND COULD BE WORTH CONSIDERING. 2005 11 582 38 DESIGNING AND VALIDATION OF A YOGA-BASED MODULE FOR OBESITY WITH METABOLIC COMORBIDITIES. OBJECTIVES: OBESITY IS A CONDITION OF INCREASED ADIPOSE TISSUE IN THE BODY, WHICH IS COMMONLY ASSOCIATED WITH VARIOUS COMORBIDITIES LIKE DIABETES, HYPERTENSION, ARTHRITIS, BACK PAIN, AND MANY OTHERS. YOGA MODULES HAVE BEEN DESIGNED AND VALIDATED FOR OBESITY; HOWEVER, WE COULDN'T FIND ANY SPECIFIC MODULE FOR METABOLIC SYNDROME, A CONDITION WHICH INCLUDES OBESITY, DIABETES MELLITUS TYPE 2 AND/OR HYPERTENSION TOGETHER. KEEPING THIS IN VIEW, OUR STUDY AIMED TO DEVELOP AND VALIDATE A SPECIFIC GENERIC YOGA-BASED INTERVENTION MODULE FOR METABOLIC SYNDROME PATIENTS. MATERIALS AND METHODS: A YOGA MODULE WAS DESIGNED BASED ON TRADITIONAL AND CONTEMPORARY YOGA LITERATURE AS WELL AS PUBLISHED STUDIES. WE DERIVED THE YOGA PRACTICES FOR THE MODULE, FROM THESE YOGA TEXTS AND RESEARCH EVIDENCE WERE ALREADY AVAILABLE. THE YOGA MODULE WAS SENT TO 40 YOGA EXPERTS FOR THEIR VALIDATION. RESULTS: TWENTY-TWO EXPERTS GAVE THEIR OPINION ON THE USEFULNESS OF A YOGA MODULE FOR PATIENTS WITH METABOLIC SYNDROME WITH SOME SUGGESTIONS. OF THESE EXPERTS, 73% WERE MALES, AND 27% WERE FEMALES. YOGA THERAPY PRACTICES WITH CONTENT VALIDITY RATIO (CVR) >0.08 WERE INCLUDED IN THE FINAL MODULE. IN TOTAL, 86% (31 OF 36 ITEMS) OF THE ITEMS IN THE INITIAL MODULE WERE RETAINED. CONCLUSION: A SPECIFIC YOGA-BASED MODULE FOR METABOLIC SYNDROME WAS DESIGNED AND VALIDATED BY EXPERTS. FURTHER STUDIES ARE NEEDED TO CONFIRM THE EFFICACY AND CLINICAL UTILITY OF THE MODULE.ADDITIONAL CLINICAL VALIDATION IS SUGGESTED. 2020 12 611 35 DEVELOPMENT OF A YOGA MODULE TARGETING CARDIOVASCULAR HEALTH FOR PATIENTS WITH POST-MYOCARDIAL LEFT VENTRICULAR DYSFUNCTION IN INDIA. BACKGROUND: YOGA IS KNOWN TO CONTRIBUTE TOWARDS CARDIOVASCULAR HEALTH. THIS PAPER DESCRIBES THE DEVELOPMENT OF A NEED-BASED YOGA PROGRAM WHICH IS SUITABLE TO BE INTEGRATED INTO THE CARDIAC REHABILITATION OF POST-MYOCARDIAL INFARCTION PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION. MATERIALS AND METHODS: BASED ON THE ASSESSMENT OF THE NEED OF THE PATIENTS, LITERATURE REVIEW, AND EXPERT OPINION, A YOGA MODULE WAS DEVELOPED USING THE QUALITATIVE METHOD OF INQUIRY. THE PROGRAM INCLUDED WARM-UP EXERCISES, YOGIC ASANAS, PRANAYAMA, MEDITATION AND COUNSELING SESSIONS. A STRUCTURED QUESTIONNAIRE ELICITING COMMENTS ON THE CONTENTS WAS GIVEN INDEPENDENTLY TO TEN EXPERTS WORKING IN THE FIELD OF HEALTH AND YOGA FOR VALIDATION. THE FINAL MODULE WAS DERIVED AFTER INCORPORATING THE SUGGESTIONS OF THE EXPERTS. RESULTS: USING THE RATERS' EXPERTISE IN CARDIOLOGY AND YOGA PRACTICE, THE PRACTICES WHICH CONSTITUTE THE MODULE WERE OPTIMIZED. MAJORITY OF THE EXPERTS (RATERS) AGREED WITH THE DURATION OF 1 H TRAINING FOR 1MONTH UNDER SUPERVISION AS ADEQUATE FOR SUBSEQUENT PRACTICE AT HOME. THERE WAS A 0.786 INTER-RATER RELIABILITY ESTIMATED USING THE INTERCLASS COEFFICIENT (ICC) AND 0.789 INTERNAL CONSISTENCY OF THE QUESTIONS, MEASURED USING CRONBACH'S ALPHA. BOTH VALUES INDICATE "GOOD" RELIABILITY AND CONSISTENCY OF THE YOGA MODULE. CONCLUSION: THE DEVELOPED YOGA MODULE WAS FOUND TO BE ACCEPTABLE. FUTURE RANDOMIZED CONTROL TRIALS WILL BE NECESSARY TO VALIDATE THE EFFECTIVENESS OF THIS MODULE AND IF THE MODULE DEMONSTRATES TO BE EFFECTIVE BY CLINICAL STUDIES, IT MAY ADD A THERAPEUTIC OPTION IN THE REHABILITATION OF PATIENTS WITH HEART FAILURE FOLLOWING MYOCARDIAL INFARCTION, WHICH CAN BE APPLIED IN THE HOSPITALS AND COMMUNITY LEVEL. 2019 13 453 35 CHANGES IN MIDAS, PERCEIVED STRESS, FRONTALIS MUSCLE ACTIVITY AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS USAGE IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA FOLLOWING AYURVEDA AND YOGA COMPARED TO CONTROLS: AN OPEN LABELED NON-RANDOMIZED STUDY. BACKGROUND: THERE HAS BEEN A SIGNIFICANT INCREASE IN THE USE OF COMPLEMENTARY AND INTEGRATIVE MEDICINE TO PROVIDE LONG-TERM HEALING SOLUTIONS IN MIGRAINE HEADACHE PATIENTS. KNOWING THE LIMITATIONS OF CONVENTIONAL MEDICAL APPROACH, THE PRESENT STUDY EVALUATED THE INFLUENCE OF TWO INDIAN TRADITIONAL SYSTEMS OF MEDICINE ON MIGRAINE-RELATED DISABILITY, AUTONOMIC VARIABLES, PERCEIVED STRESS, AND MUSCLE ACTIVITY IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA. METHODS: THIRTY SUBJECTS RECRUITED TO THE AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATION) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [NSAID'S]) FOR 90 DAYS. MIGRAINE DISABILITY ASSESSMENT SCORE, PERCEIVED STRESS, HEART RATE VARIABILITY (HRV), AND SURFACE ELECTROMYOGRAPHY (EMG) OF FRONTALIS MUSCLE WERE MEASURED ON DAY 1, DAY 30, AND DAY 90 IN BOTH GROUPS. RESULTS: SIGNIFICANT REDUCTION IN MIGRAINE DISABILITY AND PERCEIVED STRESS SCORES WERE OBSERVED IN THE AY GROUP. THE LOW-FREQUENCY COMPONENT OF THE HRV DECREASED SIGNIFICANTLY, THE HIGH-FREQUENCY COMPONENT INCREASED AND THEIR RATIO SHOWED IMPROVED SYMPATHOVAGAL BALANCE. THE EMG SHOWED DECREASED ACTIVITY OF THE FRONTALIS MUSCLE IN THE AY GROUP COMPARED TO THE CONTROL GROUP. CONCLUSION: THE INTEGRATIVE APPROACH COMBINING AYURVEDA AND YOGA THERAPY REDUCES MIGRAINE-RELATED DISABILITY, PERCEIVED STRESS, SYMPATHETIC AROUSAL, AND MUSCLE TENSION. 2018 14 613 27 DEVELOPMENT OF A YOGA PROGRAM FOR TYPE-2 DIABETES PREVENTION (YOGA-DP) AMONG HIGH-RISK PEOPLE IN INDIA. INTRODUCTION: MANY INDIANS ARE AT HIGH-RISK OF TYPE-2 DIABETES MELLITUS (T2DM). YOGA IS AN ANCIENT INDIAN MIND-BODY DISCIPLINE, THAT HAS BEEN ASSOCIATED WITH IMPROVED GLUCOSE LEVELS AND CAN HELP TO PREVENT T2DM. THE STUDY AIMED TO SYSTEMATICALLY DEVELOP A YOGA PROGRAM FOR T2DM PREVENTION (YOGA-DP) AMONG HIGH-RISK PEOPLE IN INDIA USING A COMPLEX INTERVENTION DEVELOPMENT APPROACH. MATERIALS AND METHODS: AS PART OF THE INTERVENTION, WE DEVELOPED A BOOKLET AND A HIGH-DEFINITION VIDEO FOR PARTICIPANTS AND A MANUAL FOR YOGA-DP INSTRUCTORS. A SYSTEMATIC ITERATIVE PROCESS WAS FOLLOWED TO DEVELOP THE INTERVENTION AND INCLUDED FIVE STEPS: (I) A SYSTEMATIC REVIEW OF THE LITERATURE TO GENERATE A LIST OF YOGIC PRACTICES THAT IMPROVES BLOOD GLUCOSE LEVELS AMONG ADULTS AT HIGH-RISK OF OR WITH T2DM, (II) VALIDATION OF IDENTIFIED YOGIC PRACTICES BY YOGA EXPERTS, (III) DEVELOPMENT OF THE INTERVENTION, (IV) CONSULTATION WITH YOGA, EXERCISE, PHYSICAL ACTIVITY, DIET, BEHAVIOR CHANGE, AND/OR DIABETES EXPERTS ABOUT THE INTERVENTION, AND (V) PRETEST THE INTERVENTION AMONG YOGA PRACTITIONERS AND LAY PEOPLE (THOSE AT RISK OF T2DM AND HAD NOT PRACTICED YOGA BEFORE) IN INDIA. RESULTS: YOGA-DP IS A STRUCTURED LIFESTYLE EDUCATION AND EXERCISE PROGRAM, PROVIDED OVER A PERIOD OF 24 WEEKS. THE EXERCISE PART IS BASED ON YOGA AND INCLUDES SHITHILIKARANA VYAYAMA (LOOSENING EXERCISES), SURYA NAMASKAR (SUN SALUTATION EXERCISES), ASANA (YOGIC POSES), PRANAYAMA (BREATHING PRACTICES), AND DHYANA (MEDITATION) AND RELAXATION PRACTICES. ONCE PARTICIPANTS COMPLETE THE PROGRAM, THEY ARE STRONGLY ENCOURAGED TO MAINTAIN A HEALTHY LIFESTYLE IN THE LONG-TERM. CONCLUSIONS: WE SYSTEMATICALLY DEVELOPED A NOVEL YOGA PROGRAM FOR T2DM PREVENTION (YOGA-DP) AMONG HIGH-RISK PEOPLE IN INDIA. A MULTI-CENTER FEASIBILITY RANDOMIZED CONTROLLED TRIAL IS IN PROGRESS IN INDIA. 2020 15 596 30 DEVELOPMENT AND FEASIBILITY OF YOGA THERAPY MODULE FOR OUT-PATIENTS WITH DEPRESSION IN INDIA. CONTEXT: EVIDENCE SUGGESTS THAT CERTAIN YOGA PRACTICES ARE USEFUL IN THE MANAGEMENT OF DEPRESSION. TO THE BEST OF OUR KNOWLEDGE, THERE HAS BEEN NO STUDY THAT DEALS WITH THE FORMULATION OF A YOGA MODULE FOR THE PARTICULAR CLINICAL FEATURES OF DEPRESSION. AIM: THE MAIN AIM OF OUR STUDY WAS TO DEVELOP A COMPREHENSIVE YOGA THERAPY MODULE TARGETING SPECIFIC CLINICAL FEATURES OF DEPRESSION. SETTINGS AND DESIGN: SPECIFIC YOGA PRACTICES WERE MATCHED FOR CLINICAL FEATURES OF DEPRESSION BASED ON A THOROUGH LITERATURE REVIEW. A YOGA PROGRAM WAS DEVELOPED, WHICH CONSISTED OF SUKSMAVYAYAMA, (LOOSENING EXERCISES), ASANAS (POSTURES), RELAXATION TECHNIQUES, PRANAYAMA (BREATHING EXERCISES) AND CHANTING MEDITATION TO BE TAUGHT IN A 2 WEEK PERIOD. MATERIALS AND METHODS: A STRUCTURED QUESTIONNAIRE WAS DEVELOPED FOR VALIDATION FROM NINE EXPERIENCED YOGA PROFESSIONALS. THE FINAL VERSION OF YOGA THERAPY MODULE WAS PILOT-TESTED ON SEVEN PATIENTS (FIVE FEMALES) WITH DEPRESSION RECRUITED FROM OUTPATIENT SERVICE OF NATIONAL INSTITUTE OF MENTAL HEALTH AND NEURO SCIENCES, BANGALORE. RESULTS: THE FINAL YOGA THERAPY MODULE HAD THOSE PRACTICES THAT RECEIVED A SCORE OF THREE OR MORE (MODERATELY/VERY MUCH/EXTREMELY USEFUL) FROM ALL RESPONDERS. SIX OUT OF NINE (>65%) EXPERTS SUGGESTED SUKSMAVYAYAMA SHOULD BE INCLUDED. FIVE OUT OF NINE EXPERTS OPINED THAT TRAINING WITH 10 SESSIONS (OVER 2 WEEKS) IS RATHER SHORT. ALL EXPERTS OPINED THAT THE MODULE IS EASY TO TEACH, LEARN AND PRACTICE. AT THE PILOT STAGE, THE FIVE PATIENTS WHO COMPLETED THE MODULE REPORTED MORE THAN 80% SATISFACTION ABOUT THE YOGA PRACTICES AND HOW THE YOGA WAS TAUGHT. SEVERITY OF DEPRESSION SUBSTANTIALLY REDUCED AT BOTH 1 AND 3 MONTHS FOLLOW-UP. CONCLUSION: THE DEVELOPED COMPREHENSIVE YOGA THERAPY MODULE WAS VALIDATED BY EXPERTS IN THE FIELD AND WAS FOUND TO BE FEASIBLE AND USEFUL IN PATIENTS WITH DEPRESSION. 2013 16 1374 40 IMPACT OF AN INTEGRATED YOGA THERAPY PROTOCOL ON INSULIN RESISTANCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. OBJECTIVE: DIABETES MELLITUS (DM), CHARACTERIZED BY CHRONIC HYPERGLYCEMIA, IS ATTRIBUTED TO RELATIVE INSULIN DEFICIENCY OR RESISTANCE, OR BOTH. STUDIES HAVE SHOWN THAT YOGA CAN MODULATE PARAMETERS OF INSULIN RESISTANCE. THE PRESENT STUDY EXPLORED THE POSSIBLE BENEFICIAL EFFECTS OF INTEGRATED YOGA THERAPY WITH REFERENCE TO GLYCEMIC CONTROL AND INSULIN RESISTANCE (IR) IN INDIVIDUALS WITH DIABETES MAINTAINED ON STANDARD ORAL MEDICAL CARE WITH YOGA THERAPY, COMPARED TO THOSE ON STANDARD ORAL MEDICAL CARE ALONE. METHODS: IN THIS STUDY, THE SUBJECTS ON YOGA INTERVENTION COMPRISED 35 TYPE 2 DIABETICS, AND AN EQUAL NUMBER OF VOLUNTEERS CONSTITUTED THE CONTROL GROUP. SUBJECTS RANGED IN AGE FROM 30 TO 70 YEARS, WITH HEMOGLOBIN A1C (HBA1C) TEST MORE THAN 7%, AND WERE MAINTAINED ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS. BLOOD SAMPLES WERE DRAWN PRIOR TO AND AFTER 120 DAYS OF INTEGRATED YOGA THERAPY INTERVENTION. FASTING BLOOD GLUCOSE (FBG), POST-PRANDIAL BLOOD GLUCOSE (PPBG), HBA1C, INSULIN, AND LIPID PROFILE WERE ASSESSED IN BOTH THE INTERVENTION AND CONTROL GROUPS. RESULTS: THE INTERVENTION GROUP REVEALED SIGNIFICANT IMPROVEMENTS IN BODY MASS INDEX (BMI) (0.7 KG/M(2) MEDIAN DECREASE; P=0.001), FBG (20 MG/DL MEDIAN DECREASE; P<0.001), PPBG (33 MG/DL MEDIAN DECREASE; P<0.001), HBA1C (0.4% MEDIAN DECREASE; P<0.001), HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE (HOMA-IR) (1.2 MEDIAN DECREASE; P<0.001), CHOLESTEROL (13 MG/DL MEDIAN DECREASE, P=0.006), TRIACYLGLYCEROL (22 MG/DL MEDIAN DECREASE; P=0.027), LOW-DENSITY LIPOPROTEIN (6 MG/DL MEDIAN DECREASE; P=0.004), AND VERY-LOW-DENSITY LIPOPROTEIN LEVELS (4 MG/DL MEDIAN DECREASE; P=0.032). INCREASES IN HIGH-DENSITY LIPOPROTEIN AFTER 120 DAYS WERE NOT SIGNIFICANT (6 MG/DL MEDIAN INCREASE; P=0.15). HOWEVER, WHEN COMPARED TO CHANGES OBSERVED IN PATIENTS IN THE CONTROL GROUP, ALL THESE IMPROVEMENTS PROVED TO BE SIGNIFICANT. CONCLUSION: ADMINISTRATION OF INTEGRATED YOGA THERAPY TO INDIVIDUALS WITH DIABETES LEADS TO A SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL, INSULIN RESISTANCE, AND KEY BIOCHEMICAL PARAMETERS. 2022 17 580 30 DESIGNING AND VALIDATION OF A YOGA-BASED INTERVENTION FOR OBSESSIVE COMPULSIVE DISORDER. SOME YOGA-BASED PRACTICES HAVE BEEN FOUND TO BE USEFUL FOR PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER (OCD). THE AUTHORS COULD NOT FIND A VALIDATED YOGA THERAPY MODULE AVAILABLE FOR OCD. THIS STUDY ATTEMPTED TO FORMULATE A GENERIC YOGA-BASED INTERVENTION MODULE FOR OCD. A YOGA MODULE WAS DESIGNED BASED ON TRADITIONAL AND CONTEMPORARY YOGA LITERATURE. THE MODULE WAS SENT TO 10 YOGA EXPERTS FOR CONTENT VALIDATION. THE EXPERTS RATED THE USEFULNESS OF THE PRACTICES ON A SCALE OF 1-5 (5 = EXTREMELY USEFUL). THE FINAL VERSION OF THE MODULE WAS PILOT-TESTED ON PATIENTS WITH OCD (N = 17) FOR BOTH FEASIBILITY AND EFFECT ON SYMPTOMS. EIGHTY-EIGHT PER CENT (22 OUT OF 25) OF THE ITEMS IN THE INITIAL MODULE WERE RETAINED, WITH MODIFICATIONS IN THE MODULE AS SUGGESTED BY THE EXPERTS ALONG WITH PATIENTS' INPUTS AND AUTHORS' EXPERIENCE. THE MODULE WAS FOUND TO BE FEASIBLE AND SHOWED AN IMPROVEMENT IN SYMPTOMS OF OCD ON TOTAL YALE-BROWN OBSESSIVE-COMPULSIVE SCALE (YBOCS) SCORE (P = 0.001). A GENERIC YOGA THERAPY MODULE FOR OCD WAS VALIDATED BY EXPERTS IN THE FIELD AND FOUND FEASIBLE TO PRACTICE IN PATIENTS. A DECREASE IN THE SYMPTOM SCORES WAS ALSO FOUND FOLLOWING YOGA PRACTICE OF 2 WEEKS. FURTHER CLINICAL VALIDATION IS WARRANTED TO CONFIRM EFFICACY. 2016 18 840 44 EFFECT OF YOGA ON POLYCYSTIC OVARIAN SYNDROME: A SYSTEMATIC REVIEW. POLYCYSTIC OVARIAN SYNDROME (PCOS) IS NOT A DISEASE BUT A MERE SYNDROME. MANY RESEARCHERS HAVE STUDIED POLYCYSTIC OVARIAN SYNDROME AND FOUND THAT THERE IS NO PROPER CAUSE OF THAT, IT MAY OCCUR DUE TO HORMONAL IMBALANCE OR STRESS, OR DUE TO A SEDENTARY LIFESTYLE. THE RATE OF POLYCYSTIC OVARIAN SYNDROME IN INDIAN WOMEN HAS BEEN INCREASING RAPIDLY. THE SYMPTOMS INCLUDE ACNE, WEIGHT GAIN, HIRSUTISM, DIFFICULTIES IN FERTILITY, IRREGULAR OR INFREQUENT PERIODS, IMMATURE OVARIAN EGGS THAT DO NOT OVULATE, MULTIPLE CYSTS IN THE OVARY. IF LEFT UNTREATED, IT MAY BECOME THE CAUSE FOR HEART DISEASES, DIABETES, HYPERTENSION, INFERTILITY, AND EVEN CANCER. THERE ARE VARIETIES OF MEDICAL TREATMENTS AVAILABLE TO TREAT POLYCYSTIC OVARIAN SYNDROME BUT THEY HAVE A TEMPORARY EFFECT AND IF TAKEN FOR A LONG TIME THEN IT MAY LEAD TO SERIOUS SIDE EFFECTS. YOGA HAS PROVEN EFFECTS IN REDUCING AND MANAGING THE SYMPTOMS OF POLYCYSTIC OVARIAN SYNDROME MORE EFFECTIVELY ALONG WITH MEDICINE. THIS REVIEW WORK HAS BEEN DESIGNED TO CONSIDER THE AVAILABLE LITERATURE CONCERNING THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF THE POLYCYSTIC OVARIAN SYNDROME. IT INCLUDES SOME RESEARCH PAPERS PUBLISHED BETWEEN 2012 AND 2019. BY PROVIDING YOGIC TREATMENT EFFECT ON SEVERAL PARAMETERS (SUCH AS BLOOD LIPID LEVEL, GLUCOSE METABOLISM, ENDOCRINE PARAMETERS, QUALITY OF LIFE, RESTING CARDIOVASCULAR PARAMETERS, LEVEL OF ANXIETY, DEPRESSION) ON THE WOMAN WITH POLYCYSTIC OVARIAN SYNDROME WERE MEASURED. AFTER THOROUGHLY STUDYING ABOUT 74 RESEARCH PAPERS, 16 ARE FOUND MOST RELEVANT TO BE REVIEWED. THE STUDIES OF THESE PAPERS CONCLUDED THE SUCCESSFUL USE OF DIFFERENT YOGIC LIMBS FOR THE MANAGEMENT OF POLYCYSTIC OVARIAN SYNDROME WITH OR WITHOUT MEDICATIONS. 2021 19 959 27 EFFECTS OF A YOGA INTERVENTION ON LIPID PROFILES OF DIABETES PATIENTS WITH DYSLIPIDEMIA. OBJECTIVE: THE PRESENT STUDY WAS CONDUCTED TO ASSESS THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS. METHODS: THIS RANDOMIZED PARALLEL STUDY WAS CARRIED OUT IN MEDICAL COLLEGE TRIVANDRUM, KERALA, INDIA. HUNDRED TYPE 2 DIABETICS WITH DYSLIPIDEMIA WERE RANDOMIZED INTO CONTROL AND YOGA GROUPS. THE CONTROL GROUP WAS PRESCRIBED ORAL HYPOGLYCEMIC DRUGS. THE YOGA GROUP PRACTICED YOGA DAILY FOR 1 H DURATION ALONG WITH ORAL HYPOGLYCEMIC DRUGS FOR 3 MONTHS. THE LIPID PROFILES OF BOTH THE GROUPS WERE COMPARED AT THE START AND AT THE END OF 3 MONTHS. RESULTS: AFTER INTERVENTION WITH YOGA FOR A PERIOD OF 3 MONTHS THE STUDY GROUP SHOWED A DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES AND LDL, WITH AN IMPROVEMENT IN HDL. CONCLUSION: YOGA, BEING A LIFESTYLE INCORPORATING EXERCISE AND STRESS MANAGEMENT TRAINING, TARGETS THE ELEVATED LIPID LEVELS IN PATIENTS WITH DIABETES THROUGH INTEGRATED APPROACHES. 2013 20 2530 30 YOGA EFFECTS ON ANTHROPOMETRIC INDICES AND POLYCYSTIC OVARY SYNDROME SYMPTOMS IN WOMEN UNDERGOING INFERTILITY TREATMENT: A RANDOMIZED CONTROLLED CLINICAL TRIAL. THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECTS OF YOGA EXERCISES ON ANTHROPOMETRIC PARAMETER AND CLINICAL SIGN OF PCOS AMONG WOMEN UNDERGOING INFERTILITY TREATMENT. THIS CLINICAL TRIAL STUDY WAS PERFORMED ON 61 WOMEN WITH PCOS WHO HAVE UNDERGONE INFERTILITY TREATMENT AT SAREM HOSPITAL IN TEHRAN, IRAN. THE PATIENTS WERE FIRST SELECTING BASED ON PURPOSEFUL AND THEN RANDOMLY ASSIGNING TO THE INTERVENTION AND CONTROL GROUPS. IN THE INTERVENTION GROUP, YOGA EXERCISES WERE PERFORMED FOR 6 WEEKS AND THE PATIENTS IN THE CONTROL GROUP ONLY RECEIVED ROUTINE CARE. ANTHROPOMETRIC PARAMETERS AND CLINICAL SIGNS WERE PERFORMED AND RECORDED. AFTER THE INTERVENTION, HERE WAS A SIGNIFICANT REDUCTION IN HIRSUTISM, ABDOMINAL CIRCUMFERENCE, AND HIP CIRCUMFERENCE SCORES IN THE INTERVENTION GROUP COMPARED TO THE CONTROL GROUP (P < 0.05). GIVEN THE EFFECTS OF YOGA EXERCISES ON THE IMPROVEMENT OF HIRSUTISM, ABDOMINAL CIRCUMFERENCE, AND HIP CIRCUMFERENCE, IT IS SUGGESTED TO USE YOGA AS A TREATMENT STRATEGY IN WOMEN WITH PCOS. 2021